In Vivo CAR T Generation with VivoVec

In this week's episode we’ll discuss the outcomes of younger patients with mantle cell lymphoma experiencing late relapse; learn more about mass spectrometry-based assessment of M-protein in peripheral blood during maintenance therapy in multiple myeloma and discuss in vivo CAR T-cell generation in non-human primates using lentiviral vectors.

Featured Articles: 

• Outcomes of younger patients with mantle cell lymphoma experiencing late relapse (>24 months): the LATE-POD study
• Mass spectrometry–based assessment of M protein in peripheral blood during maintenance therapy in
  multiple myeloma
• In vivo CAR T-cell generation in nonhuman primates using lentiviral vectors displaying a multidomain fusion ligand